HIGHLIGHTS
- who: Luis Ontiveros-Padilla and colleagues from the University Medical Center Groningen, Statens Serum Institut (SSI), Denmark have published the paper: Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpG, in the Journal: (JOURNAL)
- how: Statistics All in_vitro and in_vivo data were analyzed using a parametric test except survival data. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- future: Even if further studies in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.